Medtech Money Episode 27: Thomas Busby, Vice President of Healthcare & Life Science Investment Banking at Outcome Capital --- Investment Banker's Insight: Raising Capital, M&A, and U.S. Market Dynamics in the Medte
Oct 1, 2021
Thomas Busby, VP of Healthcare & Life Science Investment Banking at Outcome Capital, discusses the role of investment bankers in Medtech startups, the importance of team, money, and vision in the industry, the meaning of Outcome Capital, the due diligence process, raising capital for MedTech companies, and the current state and future outlook of the Medtech market.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Introduction
00:00 • 3min
The Importance of People, Money, and Vision in Medtech Startups
02:59 • 2min
The Meaning of Outcome Capital and the Speaker's Journey into Investment Banking
05:29 • 4min
Outcome Capital: Investing in Life Sciences and Technology
09:05 • 10min
Due Diligence Process and Timing
19:12 • 10min
Raising Capital for MedTech Startups: Insights from an Investment Banker
29:32 • 28min
Current State and Future Outlook of the Medtech Market
57:31 • 5min